CROMOLYN SODIUM

CROMOLYN SODIUM was reported 3698 times

CROMOLYN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PH BODY FLUID INCREASED 6 0.2609
1 IVTH NERVE PARESIS 3 0.1429
2 GASTROINTESTINAL SUBMUCOSAL TUMOUR 6 0.1304
3 CARDIAC VALVE SCLEROSIS 6 0.0833
4 VIRAL UVEITIS 7 0.0722
5 INDOLENT SYSTEMIC MASTOCYTOSIS 3 0.0714
6 DIFFUSE CUTANEOUS MASTOCYTOSIS 2 0.0667
7 MASTOCYTOSIS 24 0.0507
8 MAST CELL ACTIVATION SYNDROME 69 0.0491
9 PERFUME SENSITIVITY 22 0.0387
10 COSTOVERTEBRAL ANGLE TENDERNESS 6 0.0366
11 HYDROCHOLECYSTIS 6 0.0324
12 COLOUR VISION TESTS ABNORMAL 2 0.0303
13 INFUSION SITE THROMBOSIS 7 0.0261
14 BLOOD PRESSURE ORTHOSTATIC 4 0.0252
15 PERITONEAL ADHESIONS 6 0.0236
16 VASCULAR ACCESS SITE COMPLICATION 5 0.0198
17 OXYGEN SATURATION INCREASED 6 0.0177
18 WHITE COAT HYPERTENSION 9 0.0166
19 CEREBRAL ARTERIOSCLEROSIS 6 0.0155
20 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 20 0.0148
21 OMPHALITIS 4 0.0141
22 TRYPTASE INCREASED 10 0.0140
23 OESOPHAGEAL IRRITATION 8 0.0138
24 ALLERGY TO PLANTS 6 0.0131
25 BREATH HOLDING 5 0.0130
26 ALLERGY TO VACCINE 4 0.0129
27 MECHANICAL URTICARIA 6 0.0128
28 TREATMENT FAILURE 1006 0.0121
29 PO2 INCREASED 6 0.0118
30 BLADDER HYPERTROPHY 5 0.0113
31 THORACIC OUTLET SYNDROME 3 0.0112
32 LEFT ATRIAL ENLARGEMENT 6 0.0111
33 EHLERS-DANLOS SYNDROME 5 0.0108
34 SYSTEMIC MASTOCYTOSIS 3 0.0100
35 CENTRAL SLEEP APNOEA SYNDROME 3 0.0092
36 HYPOPARATHYROIDISM 6 0.0078
37 CHRONIC SPONTANEOUS URTICARIA 9 0.0078
38 EYELID CYST 2 0.0077
39 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE 3 0.0076
40 URTICARIAL VASCULITIS 4 0.0076
41 REACTION TO COLOURING 3 0.0073
42 PCO2 DECREASED 6 0.0062
43 CONJUNCTIVITIS ALLERGIC 9 0.0061
44 INFUSION SITE URTICARIA 4 0.0060
45 MYCOTIC ALLERGY 5 0.0058
46 NASAL PRURITUS 7 0.0056
47 SLEEP-RELATED EATING DISORDER 5 0.0053
48 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15 0.0051
49 INFUSION SITE DISCHARGE 9 0.0051
50 FOOD ALLERGY 39 0.0050
51 HELICOBACTER GASTRITIS 6 0.0048
52 INFUSION SITE BRUISING 10 0.0046
53 CYSTITIS INTERSTITIAL 7 0.0043
54 ADHESION 6 0.0040
55 NASAL INFLAMMATION 4 0.0038
56 NASAL DISORDER 10 0.0038
57 REACTION TO PRESERVATIVES 3 0.0037
58 ALLERGIC GRANULOMATOUS ANGIITIS 3 0.0037
59 INFUSION SITE RASH 5 0.0036
60 SLEEP TALKING 6 0.0035
61 NONINFECTIVE GINGIVITIS 5 0.0035
62 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
63 CATARACT SUBCAPSULAR 2 0.0033
64 HYPERTENSIVE HEART DISEASE 6 0.0032
65 HEREDITARY ANGIOEDEMA 34 0.0032
66 INFUSION SITE IRRITATION 4 0.0031
67 SPINAL CORD DISORDER 5 0.0030
68 ALLERGIC REACTION TO EXCIPIENT 6 0.0030
69 CONGENITAL HAND MALFORMATION 2 0.0029
70 CHRONIC FATIGUE SYNDROME 4 0.0029
71 PHARYNGEAL DISORDER 8 0.0028
72 INFUSION SITE MASS 3 0.0028
73 INFUSION SITE HAEMORRHAGE 9 0.0027
74 PHARYNGEAL SWELLING 26 0.0027
75 DISTURBANCE IN SOCIAL BEHAVIOUR 6 0.0025
76 PERIORBITAL SWELLING 14 0.0025
77 BRAIN FOG 38 0.0024
78 POST-ACUTE COVID-19 SYNDROME 3 0.0024
79 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
80 CARDIAC STRESS TEST ABNORMAL 2 0.0024
81 ARTHROPOD STING 4 0.0024
82 SUBCUTANEOUS HAEMATOMA 3 0.0023
83 APTYALISM 2 0.0023
84 ANAPHYLACTIC REACTION 129 0.0023
85 DUODENITIS 7 0.0023
86 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
87 GOITRE 9 0.0022
88 MUCOUS MEMBRANE DISORDER 3 0.0022
89 CATHETER SITE SWELLING 2 0.0021
90 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
91 GLUTEN SENSITIVITY 3 0.0021
92 NOROVIRUS INFECTION 3 0.0021
93 HYPOTHALAMO-PITUITARY DISORDER 3 0.0021
94 DIASTOLIC DYSFUNCTION 6 0.0019
95 CAROTID ARTERIOSCLEROSIS 2 0.0019
96 PRE-EXISTING CONDITION IMPROVED 12 0.0019
97 NASAL DISCOMFORT 15 0.0019
98 BLADDER PAIN 6 0.0019
99 NONSPECIFIC REACTION 10 0.0018
100 MULTIPLE ALLERGIES 14 0.0018
101 VASCULAR DEVICE INFECTION 8 0.0018
102 ENTERITIS INFECTIOUS 3 0.0018
103 ACUTE SINUSITIS 3 0.0017
104 ACUTE PRERENAL FAILURE 2 0.0017
105 SYMPTOM RECURRENCE 10 0.0017
106 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
107 NASAL OEDEMA 3 0.0017
108 BLOOD IMMUNOGLOBULIN E INCREASED 4 0.0017
109 AORTIC VALVE INCOMPETENCE 7 0.0016
110 HAEMATOLOGICAL INFECTION 4 0.0016
111 PRODUCT TASTE ABNORMAL 22 0.0016
112 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
113 DEVICE INFUSION ISSUE 4 0.0016
114 PARANASAL SINUS DISCOMFORT 6 0.0016
115 INFUSION SITE PRURITUS 5 0.0016
116 CUSHINGOID 5 0.0016
117 SINUS CONGESTION 21 0.0016
118 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
119 LYME DISEASE 5 0.0015
120 EOSINOPHILIC OESOPHAGITIS 4 0.0014
121 DISCHARGE 2 0.0014
122 LIVEDO RETICULARIS 3 0.0014
123 APHONIA 20 0.0014
124 INFUSION SITE ERYTHEMA 12 0.0014
125 CATAPLEXY 2 0.0014
126 OESOPHAGEAL STENOSIS 4 0.0014
127 DERMATITIS CONTACT 16 0.0014
128 MOUTH SWELLING 8 0.0014
129 SLEEP APNOEA SYNDROME 26 0.0014
130 SENSITIVE SKIN 10 0.0014
131 RHINITIS ALLERGIC 6 0.0013
132 EPICONDYLITIS 2 0.0013
133 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
134 ORAL PRURITUS 3 0.0013
135 BOWEL MOVEMENT IRREGULARITY 10 0.0013
136 REACTION TO EXCIPIENT 3 0.0013
137 EYE ALLERGY 2 0.0013
138 GASTRITIS EROSIVE 6 0.0013
139 SINUS PAIN 3 0.0013
140 BACTERIAL VAGINOSIS 2 0.0013
141 SWELLING OF EYELID 8 0.0013
142 INFUSION SITE SWELLING 8 0.0013
143 HEART RATE ABNORMAL 7 0.0013
144 ROTATOR CUFF SYNDROME 16 0.0012
145 SCRATCH 13 0.0012
146 THROAT TIGHTNESS 33 0.0012
147 BRADYARRHYTHMIA 2 0.0012
148 INSTILLATION SITE PAIN 3 0.0012
149 ENDODONTIC PROCEDURE 3 0.0012
150 EXCORIATION 3 0.0012
151 INFUSION SITE PAIN 15 0.0012
152 LIPOMA 3 0.0012
153 PRODUCT PACKAGING ISSUE 11 0.0012
154 SKIN SWELLING 10 0.0012
155 WEIGHT FLUCTUATION 12 0.0011
156 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
157 PRODUCT ODOUR ABNORMAL 12 0.0011
158 PERSONALITY DISORDER 3 0.0011
159 EAR PRURITUS 4 0.0011
160 CONJUNCTIVAL HYPERAEMIA 4 0.0011
161 NASAL DRYNESS 7 0.0011
162 LARYNGOSPASM 3 0.0011
163 SUSPECTED OFF LABEL USE 5 0.0011
164 FAECES SOFT 8 0.0011
165 RHINALGIA 3 0.0011
166 BODY TEMPERATURE ABNORMAL 2 0.0011
167 BLADDER SPASM 2 0.0011
168 SOMNAMBULISM 7 0.0011
169 SKIN ABRASION 5 0.0011
170 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
171 POST-TRAUMATIC STRESS DISORDER 7 0.0010
172 SKIN ATROPHY 6 0.0010
173 THYROID MASS 4 0.0010
174 ADRENAL DISORDER 2 0.0010
175 THERAPEUTIC PRODUCT INEFFECTIVE 4 0.0010
176 EARLY SATIETY 2 0.0010
177 OESOPHAGEAL CANDIDIASIS 4 0.0010
178 SKIN REACTION 14 0.0010
179 SEASONAL ALLERGY 14 0.0010
180 MUSCLE TIGHTNESS 16 0.0010
181 EYELID PAIN 2 0.0010
182 INSURANCE ISSUE 15 0.0010
183 NERVE COMPRESSION 9 0.0010
184 PRODUCT AVAILABILITY ISSUE 22 0.0010
185 TALIPES 3 0.0010
186 COMPRESSION FRACTURE 5 0.0009
187 HYPERCHOLESTEROLAEMIA 9 0.0009
188 ASTHMA 105 0.0009
189 HERPES SIMPLEX 6 0.0009
190 OEDEMA MOUTH 3 0.0009
191 TIC 5 0.0009
192 URTICARIA 152 0.0009
193 VULVOVAGINAL DISCOMFORT 4 0.0009
194 PEPTIC ULCER 3 0.0009
195 CYSTIC FIBROSIS 5 0.0009
196 PARAESTHESIA ORAL 13 0.0009
197 MENINGITIS ASEPTIC 4 0.0009
198 OBESITY 14 0.0009
199 THROAT IRRITATION 39 0.0009
200 ARTERIOSCLEROSIS 8 0.0008
201 SPINAL DISORDER 8 0.0008
202 PRODUCT CONTAMINATION 3 0.0008
203 EOSINOPHIL COUNT DECREASED 2 0.0008
204 EYE HAEMORRHAGE 11 0.0008
205 BURSITIS 10 0.0008
206 FOOD INTOLERANCE 3 0.0008
207 EYE OEDEMA 2 0.0008
208 NASAL POLYPS 4 0.0008
209 SINUS DISORDER 16 0.0008
210 PHARYNGITIS 10 0.0008
211 HYPERACUSIS 3 0.0008
212 MIGRAINE 76 0.0008
213 AUTOIMMUNE THYROIDITIS 3 0.0008
214 FACE INJURY 3 0.0008
215 ABDOMINAL INFECTION 2 0.0008
216 VIRAL INFECTION 26 0.0008
217 GASTROENTERITIS VIRAL 14 0.0008
218 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
219 CATHETER SITE PAIN 2 0.0008
220 PERIORBITAL OEDEMA 4 0.0008
221 BRADYPHRENIA 5 0.0008
222 IMPAIRED QUALITY OF LIFE 11 0.0008
223 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
224 ORAL CANDIDIASIS 10 0.0008
225 EYE SWELLING 28 0.0008
226 SWELLING FACE 49 0.0008
227 BLOOD POTASSIUM ABNORMAL 2 0.0007
228 IRRITABLE BOWEL SYNDROME 16 0.0007
229 RHINITIS 6 0.0007
230 INJECTION SITE DISCHARGE 4 0.0007
231 BRUXISM 4 0.0007
232 ADRENAL INSUFFICIENCY 9 0.0007
233 VITAMIN B12 DEFICIENCY 3 0.0007
234 HYPERSENSITIVITY 136 0.0007
235 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
236 PHOTOSENSITIVITY REACTION 12 0.0007
237 DENTAL CARIES 8 0.0007
238 STREPTOCOCCAL INFECTION 4 0.0007
239 FLUSHING 73 0.0007
240 EAR INFECTION 19 0.0007
241 SINUSITIS 73 0.0007
242 CANDIDA INFECTION 12 0.0007
243 INTERVERTEBRAL DISC DISORDER 3 0.0007
244 VITAMIN D DECREASED 6 0.0007
245 NEUROLOGICAL SYMPTOM 4 0.0007
246 HIATUS HERNIA 9 0.0007
247 FIBULA FRACTURE 2 0.0007
248 HORDEOLUM 3 0.0007
249 EYELID MARGIN CRUSTING 2 0.0007
250 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
251 MELANOCYTIC NAEVUS 3 0.0007
252 SPINAL OSTEOARTHRITIS 6 0.0007
253 EAR DISCOMFORT 7 0.0007
254 TEMPERATURE INTOLERANCE 7 0.0007
255 HEAD DISCOMFORT 12 0.0007
256 BACK DISORDER 11 0.0007
257 ARTHROPOD BITE 5 0.0007
258 SWOLLEN TONGUE 21 0.0007
259 GASTROINTESTINAL INFECTION 6 0.0007
260 HEPATITIS CHOLESTATIC 4 0.0007
261 HYPOAESTHESIA ORAL 10 0.0007
262 BONE MARROW DISORDER 2 0.0007
263 INJECTION SITE VESICLES 4 0.0007
264 RENAL PAIN 7 0.0007
265 EMERGENCY CARE 2 0.0007
266 NEURALGIA 16 0.0007
267 PROCEDURAL COMPLICATION 5 0.0007
268 LOCALISED OEDEMA 3 0.0006
269 CARPAL TUNNEL SYNDROME 9 0.0006
270 EYELIDS PRURITUS 2 0.0006
271 TASTE DISORDER 13 0.0006
272 TIBIA FRACTURE 3 0.0006
273 SECRETION DISCHARGE 8 0.0006
274 EOSINOPHILIC PNEUMONIA 2 0.0006
275 BREAST CANCER RECURRENT 2 0.0006
276 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
277 SWELLING 59 0.0006
278 FEELING JITTERY 12 0.0006
279 NASAL CONGESTION 37 0.0006
280 LACRIMATION INCREASED 19 0.0006
281 EPISTAXIS 47 0.0006
282 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
283 SNEEZING 14 0.0006
284 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
285 RESPIRATORY TRACT INFECTION 16 0.0006
286 BODY TEMPERATURE DECREASED 6 0.0006
287 BREATH SOUNDS ABNORMAL 3 0.0006
288 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
289 EOSINOPHIL COUNT INCREASED 5 0.0006
290 CONJUNCTIVITIS 11 0.0006
291 POSTOPERATIVE WOUND INFECTION 4 0.0006
292 DYSLIPIDAEMIA 3 0.0006
293 EYE IRRITATION 34 0.0006
294 PRODUCT LABEL ISSUE 4 0.0006
295 CHOLECYSTITIS 7 0.0006
296 POLYNEUROPATHY 7 0.0006
297 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
298 ECCHYMOSIS 4 0.0006
299 ANAPHYLACTIC SHOCK 15 0.0006
300 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
301 PARANOIA 10 0.0006
302 POOR VENOUS ACCESS 6 0.0006
303 MALABSORPTION 3 0.0006
304 WHEEZING 34 0.0006
305 URINE OUTPUT DECREASED 5 0.0006
306 SENSITIVITY TO WEATHER CHANGE 3 0.0006
307 EYE PAIN 32 0.0006
308 FIBRIN D DIMER INCREASED 2 0.0006
309 FOOD POISONING 3 0.0006
310 OSTEOPOROSIS 23 0.0006
311 PRODUCT DELIVERY MECHANISM ISSUE 3 0.0006
312 ERYTHEMA OF EYELID 3 0.0006
313 ASTHMATIC CRISIS 2 0.0005
314 BONE PAIN 32 0.0005
315 ORAL DISORDER 4 0.0005
316 GASTROINTESTINAL PAIN 6 0.0005
317 DRY EYE 27 0.0005
318 LIP SWELLING 18 0.0005
319 SKIN HAEMORRHAGE 8 0.0005
320 PRODUCT DISTRIBUTION ISSUE 5 0.0005
321 INTRACRANIAL PRESSURE INCREASED 3 0.0005
322 PLATELET COUNT INCREASED 7 0.0005
323 NODULE 7 0.0005
324 EYE PRURITUS 18 0.0005
325 FLANK PAIN 5 0.0005
326 EYE INFECTION 6 0.0005
327 BLOOD SODIUM DECREASED 10 0.0005
328 PAROSMIA 4 0.0005
329 CLAVICLE FRACTURE 2 0.0005
330 OEDEMA 28 0.0005
331 STRESS CARDIOMYOPATHY 3 0.0005
332 SKIN WARM 3 0.0005
333 THERAPEUTIC PRODUCT EFFECT DECREASED 23 0.0005
334 IMPAIRED GASTRIC EMPTYING 7 0.0005
335 BRONCHITIS 38 0.0005
336 SKIN LESION 14 0.0005
337 ENERGY INCREASED 3 0.0005
338 LIGAMENT SPRAIN 5 0.0005
339 PLEURISY 3 0.0005
340 ORAL DISCOMFORT 7 0.0005
341 HYPOMAGNESAEMIA 7 0.0005
342 BURNING SENSATION 35 0.0005
343 BLOOD POTASSIUM DECREASED 15 0.0005
344 CANDIDIASIS 2 0.0005
345 BLEPHARITIS 2 0.0005
346 ARTERIOSPASM CORONARY 2 0.0005
347 LEUKOCYTOSIS 9 0.0005
348 FIBROMYALGIA 12 0.0005
349 NIGHTMARE 17 0.0005
350 BRONCHOSPASM 7 0.0005
351 INITIAL INSOMNIA 5 0.0005
352 ANAPHYLACTOID REACTION 2 0.0005
353 ILLNESS 50 0.0005
354 SCOLIOSIS 3 0.0005
355 FEAR 13 0.0005
356 NECK PAIN 27 0.0005
357 MIDDLE INSOMNIA 9 0.0005
358 EYE DISCHARGE 5 0.0005
359 TENDERNESS 5 0.0005
360 FOOT FRACTURE 9 0.0005
361 ANGIOEDEMA 21 0.0005
362 ENTERITIS 3 0.0005
363 IMPAIRED WORK ABILITY 10 0.0005
364 ABNORMAL SENSATION IN EYE 2 0.0005
365 MYOPATHY 4 0.0005
366 PHARYNGITIS STREPTOCOCCAL 5 0.0005
367 HYSTERECTOMY 4 0.0005
368 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
369 OSTEOPENIA 7 0.0005
370 TENDON DISORDER 3 0.0005
371 SKIN LACERATION 5 0.0005
372 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
373 SEDATION 12 0.0005
374 OESOPHAGITIS 5 0.0005
375 DISABILITY 9 0.0005
376 PULMONARY CONGESTION 6 0.0005
377 WALKING AID USER 3 0.0005
378 PRODUCT FORMULATION ISSUE 3 0.0005
379 CORONAVIRUS INFECTION 3 0.0005
380 HYPERSOMNIA 13 0.0005
381 CATHETERISATION CARDIAC 2 0.0005
382 ABDOMINAL DISTENSION 47 0.0004
383 FUNGAL INFECTION 15 0.0004
384 MENINGITIS 3 0.0004
385 JOINT RANGE OF MOTION DECREASED 6 0.0004
386 ANAL INCONTINENCE 4 0.0004
387 OROPHARYNGEAL DISCOMFORT 4 0.0004
388 SCAB 5 0.0004
389 MICTURITION URGENCY 5 0.0004
390 MENTAL DISORDER 19 0.0004
391 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
392 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
393 LARGE INTESTINE POLYP 3 0.0004
394 ARTHRITIS INFECTIVE 2 0.0004
395 CHEST DISCOMFORT 44 0.0004
396 HEPATIC STEATOSIS 8 0.0004
397 FEELING OF DESPAIR 2 0.0004
398 ERECTILE DYSFUNCTION 11 0.0004
399 SPLENOMEGALY 5 0.0004
400 GASTROINTESTINAL DISORDER 38 0.0004
401 COVID-19 PNEUMONIA 5 0.0004
402 HYPOCALCAEMIA 8 0.0004
403 DIVERTICULUM 3 0.0004
404 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
405 RETCHING 9 0.0004
406 SPUTUM DISCOLOURED 4 0.0004
407 LIMB DISCOMFORT 13 0.0004
408 WRIST FRACTURE 5 0.0004
409 CHOLESTASIS 8 0.0004
410 AFFECT LABILITY 4 0.0004
411 TONGUE DISORDER 3 0.0004
412 DERMATITIS BULLOUS 3 0.0004
413 TINNITUS 19 0.0004
414 INTENTIONAL PRODUCT USE ISSUE 36 0.0004
415 INTENTIONAL UNDERDOSE 3 0.0004
416 MAJOR DEPRESSION 3 0.0004
417 AUTOIMMUNE DISORDER 4 0.0004
418 VITAMIN D DEFICIENCY 4 0.0004
419 SKIN FISSURES 8 0.0004
420 FREQUENT BOWEL MOVEMENTS 11 0.0004
421 HEPATOMEGALY 4 0.0004
422 VITREOUS FLOATERS 4 0.0004
423 INFLAMMATION 21 0.0004
424 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
425 CONDITION AGGRAVATED 123 0.0004
426 EXPIRED DRUG ADMINISTERED 2 0.0004
427 FOOT OPERATION 2 0.0004
428 GENERALISED OEDEMA 5 0.0004
429 FEELING DRUNK 3 0.0004
430 IMMUNODEFICIENCY 6 0.0004
431 RHINORRHOEA 26 0.0004
432 HYPOTONIA 4 0.0004
433 OCULAR HYPERAEMIA 19 0.0004
434 DERMATITIS ATOPIC 21 0.0004
435 EMPHYSEMA 4 0.0004
436 EYE DISORDER 13 0.0004
437 EYELID PTOSIS 4 0.0004
438 FEMORAL NECK FRACTURE 2 0.0004
439 RENAL FAILURE CHRONIC 3 0.0004
440 THYROID DISORDER 6 0.0004
441 ATRIOVENTRICULAR BLOCK 3 0.0004
442 FLATULENCE 22 0.0004
443 CONCUSSION 3 0.0004
444 FAILURE TO THRIVE 2 0.0004
445 VENTRICULAR EXTRASYSTOLES 4 0.0004
446 THERAPY PARTIAL RESPONDER 6 0.0004
447 CONTUSION 37 0.0004
448 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
449 FOOD CRAVING 2 0.0004
450 NASOPHARYNGITIS 70 0.0004
451 BLOOD PRESSURE INCREASED 58 0.0004
452 TOOTH INFECTION 5 0.0004
453 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
454 RENAL CYST 3 0.0004
455 PRODUCTIVE COUGH 18 0.0004
456 CELLULITIS 19 0.0004
457 DYSGEUSIA 28 0.0004
458 ANORECTAL DISCOMFORT 2 0.0004
459 HYPOTHYROIDISM 12 0.0004
460 ABDOMINAL DISCOMFORT 63 0.0004
461 JOINT INJURY 8 0.0004
462 BLOOD DISORDER 3 0.0004
463 HEART RATE INCREASED 37 0.0004
464 HEPATIC CIRRHOSIS 7 0.0004
465 PRURITUS 143 0.0004
466 STENT PLACEMENT 3 0.0004
467 RASH MACULAR 13 0.0004
468 PRODUCT DOSE OMISSION ISSUE 109 0.0004
469 MUSCLE DISORDER 3 0.0004
470 CHEILITIS 2 0.0004
471 BACK INJURY 4 0.0004
472 ABNORMAL FAECES 3 0.0004
473 HICCUPS 3 0.0004
474 BLOOD GLUCOSE FLUCTUATION 4 0.0004
475 MYALGIA 62 0.0004
476 ASTHENOPIA 2 0.0004
477 GLAUCOMA 7 0.0004
478 FEELING ABNORMAL 87 0.0004
479 CHOKING SENSATION 2 0.0004
480 MASS 5 0.0004
481 MALNUTRITION 4 0.0004
482 KIDNEY INFECTION 7 0.0004
483 SKIN INFECTION 4 0.0004
484 OROPHARYNGEAL PAIN 33 0.0004
485 SENSATION OF FOREIGN BODY 3 0.0004
486 CHROMATURIA 8 0.0004
487 REBOUND EFFECT 4 0.0004
488 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
489 HAEMATOCRIT DECREASED 7 0.0004
490 INTENTIONAL DOSE OMISSION 10 0.0004
491 PRODUCT CONTAINER ISSUE 3 0.0003
492 CARDIAC VALVE DISEASE 2 0.0003
493 IRRITABILITY 21 0.0003
494 CARDIAC OPERATION 3 0.0003
495 MUSCLE SPASMS 64 0.0003
496 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
497 DYSPEPSIA 34 0.0003
498 FEEDING DISORDER 7 0.0003
499 VERTIGO 21 0.0003
500 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
501 GASTRITIS 9 0.0003
502 DYSPHONIA 20 0.0003
503 PURPURA 3 0.0003
504 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
505 TOOTH LOSS 7 0.0003
506 ATAXIA 4 0.0003
507 FACIAL PAIN 3 0.0003
508 MYOCLONUS 4 0.0003
509 PRODUCT USE IN UNAPPROVED INDICATION 83 0.0003
510 JAUNDICE 9 0.0003
511 ENDOPHTHALMITIS 2 0.0003
512 PALPITATIONS 39 0.0003
513 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
514 LIMB INJURY 9 0.0003
515 INSOMNIA 88 0.0003
516 ECONOMIC PROBLEM 5 0.0003
517 NOCTURIA 4 0.0003
518 FEELING HOT 20 0.0003
519 ABDOMINAL PAIN UPPER 67 0.0003
520 CARDIOMEGALY 4 0.0003
521 POOR QUALITY SLEEP 7 0.0003
522 PHARYNGEAL OEDEMA 5 0.0003
523 GRAND MAL CONVULSION 3 0.0003
524 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
525 MUSCULOSKELETAL CHEST PAIN 5 0.0003
526 CHOLANGITIS 2 0.0003
527 THINKING ABNORMAL 6 0.0003
528 BACTERIAL INFECTION 6 0.0003
529 HAIR COLOUR CHANGES 4 0.0003
530 COGNITIVE DISORDER 15 0.0003
531 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
532 PAIN IN JAW 9 0.0003
533 HEADACHE 199 0.0003
534 PRODUCT USE COMPLAINT 5 0.0003
535 HALLUCINATION, AUDITORY 5 0.0003
536 RECALLED PRODUCT ADMINISTERED 3 0.0003
537 COUGH 88 0.0003
538 FOREIGN BODY SENSATION IN EYES 2 0.0003
539 INTRAOCULAR PRESSURE INCREASED 4 0.0003
540 PRODUCT SUBSTITUTION ISSUE 18 0.0003
541 HYPOXIA 11 0.0003
542 RASH PAPULAR 7 0.0003
543 INFECTION 45 0.0003
544 EAR PAIN 6 0.0003
545 NERVOUSNESS 16 0.0003
546 COELIAC DISEASE 3 0.0003
547 THERAPY CHANGE 3 0.0003
548 FATIGUE 237 0.0003
549 IMMUNE SYSTEM DISORDER 4 0.0003
550 DEPRESSED MOOD 16 0.0003
551 CHEST PAIN 56 0.0003
552 COVID-19 53 0.0003
553 INABILITY TO AFFORD MEDICATION 3 0.0003
554 INFUSION RELATED REACTION 20 0.0003
555 ADVERSE REACTION 4 0.0003
556 UNDERDOSE 22 0.0003
557 DRUG INTOLERANCE 29 0.0003
558 OVARIAN CYST 3 0.0003
559 SALIVARY HYPERSECRETION 3 0.0003
560 INJECTION SITE PRURITUS 20 0.0003
561 QUALITY OF LIFE DECREASED 4 0.0003
562 DISCOMFORT 18 0.0003
563 GINGIVAL BLEEDING 4 0.0003
564 RIB FRACTURE 6 0.0003
565 ENCEPHALITIS 2 0.0003
566 PRESYNCOPE 7 0.0003
567 PETECHIAE 3 0.0003
568 ERYTHEMA 59 0.0003
569 ECZEMA 15 0.0003
570 EXTRASYSTOLES 2 0.0003
571 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
572 DYSPNOEA 161 0.0003
573 INCONTINENCE 3 0.0003
574 LYMPHADENOPATHY 10 0.0003
575 HYPOKALAEMIA 13 0.0003
576 TACHYCARDIA 25 0.0003
577 GALLBLADDER DISORDER 5 0.0003
578 NIGHT SWEATS 9 0.0003
579 SKIN CANCER 6 0.0003
580 DISTURBANCE IN ATTENTION 15 0.0003
581 DECREASED ACTIVITY 3 0.0003
582 ANOSMIA 4 0.0003
583 HYPOKINESIA 4 0.0003
584 DYSPHAGIA 26 0.0003
585 STAPHYLOCOCCAL INFECTION 9 0.0003
586 DIZZINESS 136 0.0003
587 BLINDNESS TRANSIENT 2 0.0003
588 BLOOD PRESSURE DECREASED 18 0.0003
589 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
590 CEREBRAL DISORDER 2 0.0003
591 RASH GENERALISED 7 0.0003
592 URINARY INCONTINENCE 8 0.0003
593 NERVE INJURY 3 0.0003
594 DIARRHOEA 174 0.0003
595 MALAISE 118 0.0003
596 AGRANULOCYTOSIS 5 0.0003
597 RESPIRATORY DISORDER 8 0.0003
598 OCULAR DISCOMFORT 3 0.0003
599 ABDOMINAL PAIN 62 0.0003
600 PHOTOPHOBIA 5 0.0003
601 BREAST TENDERNESS 2 0.0003
602 IMPAIRED DRIVING ABILITY 3 0.0003
603 ANXIETY 75 0.0003
604 ILL-DEFINED DISORDER 16 0.0003
605 AORTIC ANEURYSM 2 0.0003
606 NAUSEA 208 0.0003
607 MUSCULOSKELETAL DISORDER 5 0.0003
608 DISSOCIATION 2 0.0003
609 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
610 SEROTONIN SYNDROME 5 0.0003
611 PERIPHERAL SWELLING 40 0.0003
612 EMOTIONAL DISORDER 8 0.0003
613 AGITATION 19 0.0003
614 EYELID OEDEMA 3 0.0003
615 WEIGHT DECREASED 72 0.0003
616 APNOEA 2 0.0003
617 HAEMORRHOIDS 5 0.0003
618 ORAL HERPES 5 0.0003
619 CHILLS 30 0.0003
620 FLUID RETENTION 13 0.0003
621 VISION BLURRED 35 0.0003
622 BALANCE DISORDER 22 0.0003
623 BLOOD ALBUMIN DECREASED 2 0.0003
624 DRUG INEFFECTIVE 332 0.0003
625 ULCER 4 0.0003
626 HYPERLIPIDAEMIA 3 0.0003
627 PRODUCT QUALITY ISSUE 34 0.0003
628 SENSORY DISTURBANCE 4 0.0002
629 THROMBOSIS 20 0.0002
630 PARAESTHESIA 39 0.0002
631 CONFUSIONAL STATE 40 0.0002
632 PRODUCT ADMINISTRATION ERROR 5 0.0002
633 HYPOAESTHESIA 37 0.0002
634 URINARY TRACT INFECTION 42 0.0002
635 ADVERSE DRUG REACTION 22 0.0002
636 SPINAL OPERATION 3 0.0002
637 INJECTION SITE EXTRAVASATION 3 0.0002
638 ESCHERICHIA INFECTION 2 0.0002
639 CYST 3 0.0002
640 DRUG LEVEL INCREASED 4 0.0002
641 TOOTH EXTRACTION 3 0.0002
642 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
643 EMBOLISM 2 0.0002
644 RASH PRURITIC 13 0.0002
645 DYSPNOEA EXERTIONAL 9 0.0002
646 SURGERY 14 0.0002
647 CONSTIPATION 52 0.0002
648 TYPE 2 DIABETES MELLITUS 8 0.0002
649 HEMIPARESIS 4 0.0002
650 INJECTION SITE IRRITATION 3 0.0002
651 HAEMATOCHEZIA 13 0.0002
652 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
653 SOMNOLENCE 47 0.0002
654 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
655 INFLUENZA 26 0.0002
656 MEMORY IMPAIRMENT 32 0.0002
657 MUSCULOSKELETAL DISCOMFORT 4 0.0002
658 BLOOD MAGNESIUM DECREASED 2 0.0002
659 BLISTER 13 0.0002
660 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
661 THERAPEUTIC RESPONSE DECREASED 14 0.0002
662 INFLUENZA LIKE ILLNESS 19 0.0002
663 RASH ERYTHEMATOUS 11 0.0002
664 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
665 EOSINOPHILIA 4 0.0002
666 BACK PAIN 53 0.0002
667 BLOOD CALCIUM INCREASED 2 0.0002
668 RASH 99 0.0002
669 SEIZURE 26 0.0002
670 TOOTH DISORDER 5 0.0002
671 UNEVALUABLE EVENT 17 0.0002
672 LUNG DISORDER 11 0.0002
673 DEPRESSION 51 0.0002
674 PYREXIA 77 0.0002
675 OSTEOMYELITIS 4 0.0002
676 RESTLESS LEGS SYNDROME 4 0.0002
677 SYNCOPE 22 0.0002
678 CYSTITIS 7 0.0002
679 BONE DISORDER 4 0.0002
680 EXOSTOSIS 2 0.0002
681 ARTHRALGIA 91 0.0002
682 PERIPHERAL COLDNESS 3 0.0002
683 PAIN 134 0.0002
684 BRAIN NEOPLASM 2 0.0002
685 HYPERHIDROSIS 28 0.0002
686 DYSURIA 8 0.0002
687 MUSCLE TWITCHING 5 0.0002
688 ARTHRITIS 17 0.0002
689 AMNESIA 14 0.0002
690 RENAL DISORDER 10 0.0002
691 GAIT DISTURBANCE 41 0.0002
692 OXYGEN SATURATION DECREASED 12 0.0002
693 BLOOD TEST ABNORMAL 3 0.0002
694 CHOLELITHIASIS 7 0.0002
695 VOMITING 100 0.0002
696 BLINDNESS UNILATERAL 3 0.0002
697 SLEEP DISORDER 15 0.0002
698 MUSCULAR WEAKNESS 24 0.0002
699 TREMOR 35 0.0002
700 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
701 EXPIRED PRODUCT ADMINISTERED 7 0.0002
702 EYE INFLAMMATION 2 0.0002
703 LETHARGY 12 0.0002
704 ATELECTASIS 2 0.0002
705 LOCALISED INFECTION 5 0.0002
706 ERUCTATION 4 0.0002
707 NEEDLE ISSUE 6 0.0002
708 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
709 GASTROENTERITIS 3 0.0002
710 OFF LABEL USE 179 0.0002
711 INJECTION SITE URTICARIA 5 0.0002
712 LIVER INJURY 5 0.0002
713 DISORIENTATION 8 0.0002
714 BLOOD PRESSURE ABNORMAL 4 0.0002
715 UPPER LIMB FRACTURE 4 0.0002
716 BRAIN INJURY 2 0.0002
717 APHASIA 6 0.0002
718 PRODUCT PHYSICAL ISSUE 4 0.0002
719 PRODUCT USE ISSUE 37 0.0002
720 DRY THROAT 2 0.0002
721 DRUG DISPENSING ERROR 3 0.0002
722 NEPHROLITHIASIS 9 0.0002
723 ANKLE FRACTURE 3 0.0002
724 TENDONITIS 3 0.0002
725 EXPOSURE VIA SKIN CONTACT 5 0.0002
726 CRYING 7 0.0002
727 DIPLOPIA 5 0.0002
728 NERVOUS SYSTEM DISORDER 6 0.0002
729 PANIC ATTACK 7 0.0002
730 POLLAKIURIA 8 0.0002
731 SPEECH DISORDER 10 0.0002
732 CYANOSIS 3 0.0002
733 FOLLICULITIS 2 0.0002
734 JOINT STIFFNESS 5 0.0002
735 ANHEDONIA 5 0.0002
736 HALLUCINATION, VISUAL 4 0.0002
737 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
738 MOOD SWINGS 6 0.0002
739 ABSCESS 3 0.0002
740 ASTHENIA 70 0.0002
741 CATARACT 11 0.0002
742 PALLOR 5 0.0002
743 PRODUCT PRESCRIBING ISSUE 4 0.0002
744 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
745 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
746 RESPIRATORY DISTRESS 5 0.0002
747 ABNORMAL DREAMS 5 0.0002
748 FOOT DEFORMITY 2 0.0002
749 DEHYDRATION 24 0.0002
750 MEDICATION ERROR 10 0.0002
751 SKIN DISORDER 6 0.0002
752 URINARY RETENTION 6 0.0002
753 SEPSIS 20 0.0002
754 WOUND 5 0.0002
755 WEIGHT INCREASED 40 0.0002
756 ALOPECIA 35 0.0002
757 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
758 HEART RATE IRREGULAR 4 0.0002
759 CHOLECYSTECTOMY 2 0.0002
760 SUICIDAL IDEATION 16 0.0002
761 ANGINA PECTORIS 5 0.0002
762 DELIRIUM 6 0.0002
763 OEDEMA PERIPHERAL 21 0.0002
764 DYSKINESIA 7 0.0002
765 LOCAL SWELLING 3 0.0002
766 LOSS OF CONSCIOUSNESS 22 0.0002
767 HEART RATE DECREASED 6 0.0002
768 COLD SWEAT 3 0.0002
769 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
770 DRUG ERUPTION 3 0.0002
771 BLOOD IRON DECREASED 2 0.0002
772 PULMONARY EMBOLISM 16 0.0002
773 ROAD TRAFFIC ACCIDENT 7 0.0002
774 GOUT 3 0.0002
775 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
776 PAIN IN EXTREMITY 49 0.0002
777 SKIN EXFOLIATION 14 0.0002
778 TOOTHACHE 3 0.0002
779 HYPERTENSION 35 0.0002
780 OSTEOARTHRITIS 7 0.0002
781 MENTAL IMPAIRMENT 4 0.0002
782 BLOOD GLUCOSE ABNORMAL 3 0.0002
783 FALL 54 0.0002
784 ABASIA 4 0.0002
785 DRY MOUTH 13 0.0002
786 MUSCULOSKELETAL STIFFNESS 14 0.0002
787 DYSARTHRIA 6 0.0002
788 HOT FLUSH 12 0.0002
789 DERMATITIS ALLERGIC 2 0.0002
790 BRAIN OEDEMA 2 0.0002
791 HEAD INJURY 5 0.0002
792 PRODUCT COMPLAINT 4 0.0002
793 DIABETES MELLITUS 12 0.0002
794 JOINT SWELLING 19 0.0002
795 PULMONARY FIBROSIS 3 0.0002
796 LOWER LIMB FRACTURE 3 0.0002
797 DRUG PRESCRIBING ERROR 3 0.0002
798 THERAPY NON-RESPONDER 7 0.0002
799 ANOREXIA 2 0.0002
800 HERNIA 3 0.0002
801 DECREASED APPETITE 36 0.0002
802 THERAPY INTERRUPTED 11 0.0002
803 MOBILITY DECREASED 11 0.0002
804 HAEMORRHAGE 16 0.0002
805 DEAFNESS 4 0.0002
806 ANKYLOSING SPONDYLITIS 2 0.0002
807 INJECTION SITE BRUISING 12 0.0002
808 DRY SKIN 20 0.0001
809 SPINAL FRACTURE 3 0.0001
810 GAIT INABILITY 5 0.0001
811 DRUG EFFECT DECREASED 8 0.0001
812 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
813 ARRHYTHMIA 7 0.0001
814 DISEASE RECURRENCE 7 0.0001
815 MOOD ALTERED 4 0.0001
816 AKATHISIA 2 0.0001
817 INJECTION SITE WARMTH 3 0.0001
818 CORONARY ARTERY OCCLUSION 2 0.0001
819 BLOOD GLUCOSE DECREASED 7 0.0001
820 INJECTION SITE REACTION 10 0.0001
821 DIVERTICULITIS 4 0.0001
822 PROCEDURAL PAIN 4 0.0001
823 FEELING COLD 4 0.0001
824 COORDINATION ABNORMAL 2 0.0001
825 EATING DISORDER 3 0.0001
826 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
827 RED BLOOD CELL COUNT DECREASED 4 0.0001
828 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
829 INJECTION SITE HAEMORRHAGE 11 0.0001
830 PRODUCT STORAGE ERROR 12 0.0001
831 RESTLESSNESS 5 0.0001
832 MELAENA 3 0.0001
833 LABORATORY TEST ABNORMAL 4 0.0001
834 PSYCHOTIC DISORDER 4 0.0001
835 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
836 CARDIOMYOPATHY 2 0.0001
837 STEVENS-JOHNSON SYNDROME 3 0.0001
838 COLON CANCER 2 0.0001
839 ORAL PAIN 3 0.0001
840 MUSCULOSKELETAL PAIN 7 0.0001
841 BONE LOSS 2 0.0001
842 STOMATITIS 8 0.0001
843 COLITIS 5 0.0001
844 EPILEPSY 4 0.0001
845 INJECTION SITE SWELLING 10 0.0001
846 INJECTION SITE RASH 4 0.0001
847 DEVICE RELATED INFECTION 2 0.0001
848 PERICARDIAL EFFUSION 3 0.0001
849 FEMUR FRACTURE 4 0.0001
850 DELUSION 2 0.0001
851 EJECTION FRACTION DECREASED 2 0.0001
852 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
853 NEUROPATHY PERIPHERAL 12 0.0001
854 SKIN BURNING SENSATION 9 0.0001
855 ABORTION SPONTANEOUS 5 0.0001
856 PNEUMONIA 40 0.0001
857 EXTRA DOSE ADMINISTERED 5 0.0001
858 DEEP VEIN THROMBOSIS 8 0.0001
859 INCORRECT DOSE ADMINISTERED 28 0.0001
860 DEVICE ISSUE 11 0.0001
861 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
862 COAGULOPATHY 2 0.0001
863 HYPOTENSION 24 0.0001
864 WITHDRAWAL SYNDROME 5 0.0001
865 HAEMATEMESIS 3 0.0001
866 ANGER 4 0.0001
867 HEPATIC ENZYME INCREASED 8 0.0001
868 THERAPY CESSATION 6 0.0001
869 HAEMATURIA 4 0.0001
870 RECTAL HAEMORRHAGE 5 0.0001
871 UNRESPONSIVE TO STIMULI 3 0.0001
872 SKIN ULCER 3 0.0001
873 HAEMATOMA 3 0.0001
874 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
875 SUICIDE ATTEMPT 7 0.0001
876 SEPTIC SHOCK 5 0.0001
877 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
878 INJURY 8 0.0001
879 BRADYCARDIA 6 0.0001
880 ATRIAL FIBRILLATION 11 0.0001
881 PLATELET COUNT DECREASED 12 0.0001
882 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
883 BREAST CANCER FEMALE 3 0.0001
884 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
885 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
886 SKIN DISCOLOURATION 5 0.0001
887 MENTAL STATUS CHANGES 3 0.0001
888 ARTHROPATHY 6 0.0001
889 HAEMOPTYSIS 3 0.0001
890 BLOOD CREATININE INCREASED 7 0.0001
891 DRUG INTERACTION 17 0.0001
892 RENAL IMPAIRMENT 9 0.0001
893 INTESTINAL OBSTRUCTION 4 0.0001
894 ACNE 8 0.0001
895 CHRONIC KIDNEY DISEASE 8 0.0001
896 HERPES ZOSTER 6 0.0001
897 ACUTE RESPIRATORY FAILURE 2 0.0001
898 DYSSTASIA 3 0.0001
899 CHOKING 2 0.0001
900 ABNORMAL BEHAVIOUR 4 0.0001
901 LEUKOPENIA 5 0.0001
902 HEPATIC FAILURE 3 0.0001
903 CORONARY ARTERY DISEASE 3 0.0001
904 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
905 BLINDNESS 4 0.0001
906 NEUTROPHIL COUNT DECREASED 4 0.0001
907 BODY TEMPERATURE INCREASED 2 0.0001
908 RENAL FAILURE 13 0.0001
909 DRUG ADMINISTRATION ERROR 3 0.0001
910 HAEMOGLOBIN DECREASED 10 0.0001
911 RHEUMATOID ARTHRITIS 11 0.0001
912 INJECTION SITE ERYTHEMA 12 0.0001
913 BONE DENSITY DECREASED 3 0.0001
914 DRUG-INDUCED LIVER INJURY 3 0.0001
915 BLOOD GLUCOSE INCREASED 18 0.0001
916 PANCREATITIS 5 0.0001
917 CEREBROVASCULAR ACCIDENT 16 0.0001
918 MOVEMENT DISORDER 3 0.0001
919 HIP FRACTURE 3 0.0001
920 IMPAIRED HEALING 3 0.0001
921 EMOTIONAL DISTRESS 11 0.0001
922 APPLICATION SITE PAIN 2 0.0001
923 NEOPLASM MALIGNANT 6 0.0001
924 VISUAL IMPAIRMENT 11 0.0001
925 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
926 DEVICE MALFUNCTION 6 0.0001
927 INJECTION SITE PAIN 26 0.0001
928 HOSPITALISATION 13 0.0001
929 BLOOD PRESSURE FLUCTUATION 2 0.0001
930 NO ADVERSE EVENT 15 0.0001
931 INTERSTITIAL LUNG DISEASE 4 0.0001
932 PLEURAL EFFUSION 5 0.0001
933 ENCEPHALOPATHY 2 0.0001
934 INJECTION SITE MASS 3 0.0001
935 THROMBOCYTOPENIA 9 0.0001
936 AGEUSIA 2 0.0001
937 INTENTIONAL PRODUCT MISUSE 7 0.0001
938 ABDOMINAL PAIN LOWER 2 0.0001
939 CARDIOVASCULAR DISORDER 2 0.0001
940 CARDIAC FAILURE 6 0.0001
941 BLOOD BILIRUBIN INCREASED 2 0.0001
942 PSORIATIC ARTHROPATHY 3 0.0001
943 TREATMENT NONCOMPLIANCE 4 0.0001
944 DEMENTIA 2 0.0001
945 HYPONATRAEMIA 4 0.0001
946 RENAL FAILURE ACUTE 3 0.0001
947 HYPOACUSIS 3 0.0001
948 DEVICE LEAKAGE 3 0.0001
949 VAGINAL HAEMORRHAGE 3 0.0001
950 RESPIRATORY FAILURE 5 0.0001
951 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
952 ANAEMIA 13 0.0001
953 ASCITES 2 0.0001
954 ACUTE MYOCARDIAL INFARCTION 2 0.0001
955 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
956 SKIN IRRITATION 3 0.0001
957 ACUTE KIDNEY INJURY 10 0.0001
958 ADVERSE EVENT 6 0.0001
959 BLOOD CHOLESTEROL INCREASED 3 0.0001
960 CARDIAC DISORDER 6 0.0001
961 COMA 3 0.0001
962 CARDIAC ARREST 5 0.0001
963 AGGRESSION 3 0.0001
964 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
966 C-REACTIVE PROTEIN INCREASED 2 0.0001
967 DEPENDENCE 3 0.0001
968 PANCYTOPENIA 3 0.0001
969 HALLUCINATION 4 0.0001
970 CONVULSION 3 0.0001
971 MYOCARDIAL INFARCTION 9 0.0001
972 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
973 DEVICE BREAKAGE 2 0.0000
974 DRUG DOSE OMISSION 8 0.0000
975 EXPOSURE DURING PREGNANCY 3 0.0000
976 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
977 CARDIO-RESPIRATORY ARREST 2 0.0000
978 TOXICITY TO VARIOUS AGENTS 8 0.0000
979 PRODUCT DOSE OMISSION 3 0.0000
980 DEVICE DIFFICULT TO USE 3 0.0000
981 COLITIS ULCERATIVE 2 0.0000
982 PSORIASIS 5 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
984 DRUG ABUSE 3 0.0000
985 DRUG WITHDRAWAL SYNDROME 3 0.0000
986 DISEASE PROGRESSION 4 0.0000
987 BREAST CANCER 3 0.0000
988 DRUG DEPENDENCE 5 0.0000
989 CARDIAC FAILURE CONGESTIVE 2 0.0000
990 DEATH 21 0.0000
991 OVERDOSE 5 0.0000